The IDH1/2 mutations can produce a high level of 2-HG to inhibit the differentiation of glioma stem cells, upregulate the formation of the tumor microenvironment, and produce a high level of HIF-1α to promote the invasion of glioma. This evidence concerns the gene IDH1 and central nervous system cancer.